SCHEMBL5151298

SCHEMBL5151298

CCOc1ccc(-c2cccc(C(C)C)c2)cc1C(=O)N[C@@H](CO)Cc1c[nH]c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HTT P42858 1/20 0.47
ECE1 P42892 1/20 0.45
MAPT P10636 5/20 0.43
HPGD P15428 3/20 0.43
ALDH1A1 P00352 2/20 0.43
THRB P10828 2/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HPGDS O60760 1/20 0.43
HDAC3 O15379 3/20 0.43
HDAC4 P56524 3/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC7 Q8WUI4 3/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC10 Q969S8 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
HDAC8 Q9BY41 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14557894 0.91 MAPT (0.47) POLBMEN1KMT2AECE1MAPT
SCHEMBL14557598 0.91 MAPT (0.49) POLBMEN1KMT2AMAPTHPGD
SCHEMBL14557620 0.90 MAPT (0.49) POLBMEN1KMT2AMAPTHPGD
SCHEMBL14610784 0.90 MAPT (0.49) POLBMEN1KMT2AMAPTHPGD
SCHEMBL14610419 0.90 HPGDS (0.54) POLBMEN1KMT2AMAPTHPGD
SCHEMBL14557783 0.89 MMP2 (0.45) POLBMEN1KMT2AHTTMAPT
SCHEMBL14610459 0.89 ITGB2 (0.45) POLBMEN1KMT2AECE1MAPT
SCHEMBL14611098 0.89 HPGDS (0.45) POLBMEN1KMT2AMAPTHPGD
SCHEMBL14557616 0.89 ITGB2 (0.49) POLBMEN1KMT2AMAPTHPGD
SCHEMBL14557895 0.89 HPGDS (0.45) POLBMEN1KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R POLB 4403/4885MEN1 410/4885KMT2A 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.